All News

    Managing Cancer Demands With Flexibility and a Strategic Mindset

    April 10th 2025, 5:00pm

    Article

    It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and patience.

    FDA Grants Full Approval to Vitrakvi For NTRK-Positive Solid Tumors

    April 10th 2025, 2:47pm

    Article

    Vitrakvi, first granted accelerated approval in 2018, has received full approval from the FDA.

    Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award

    April 10th 2025, 1:15pm

    Article

    The 2025 Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impact.

    First Patient Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors

    April 9th 2025, 9:00pm

    Article

    CT-95 is being developed for cancers including pancreatic, ovarian and mesothelioma and other solid tumors.

    Early Detection and Screening is Key for Esophageal Cancer

    April 9th 2025, 8:29pm

    Video

    Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.

    Breaking Down Treatment Options for Patients With Head and Neck Cancer

    April 9th 2025, 7:00pm

    Article

    Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.

    Going Off Medication for Lymphoma: Could It Be True?

    April 9th 2025, 5:00pm

    Article

    After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly taking me off of it.

    PROSTOX May Predict Urinary Side Effects Post Prostate Cancer Radiation

    April 9th 2025, 3:00pm

    Article

    A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.

    Early Intervention and Screening Prevents Lymphedema After Cancer

    April 9th 2025, 1:03pm

    Article

    Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.

    FDA Grants Positive Review for AML Drug Trial, First Dosing in 2025

    April 8th 2025, 9:00pm

    Article

    The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.